Cargando…

Testing the application of polygenic risk scores in the transplant setting – Relevance for precision medicine

Detalles Bibliográficos
Autores principales:	Shaked, Abraham, Loza, Bao‐Li, Olthoff, Kim, Keating, Brendan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377149/ https://www.ncbi.nlm.nih.gov/pubmed/35968930 http://dx.doi.org/10.1002/ctm2.1009

Ejemplares similares

Interpreting polygenic scores, polygenic adaptation, and human phenotypic differences
por: Rosenberg, Noah A, et al.
Publicado: (2018)

Statistical genetics and polygenic risk score for precision medicine
por: Konuma, Takahiro, et al.
Publicado: (2021)

Missing heritability, polygenic scores, and gene–environment correlation
por: Plomin, Robert
Publicado: (2013)

Polygenic risk scores in the clinic: Translating risk into action
por: Lewis, Anna C.F., et al.
Publicado: (2021)

The False Dawn of Polygenic Risk Scores for Human Disease Prediction
por: Herzig, Anthony F., et al.
Publicado: (2022)

Polygenic risk scores for complex diseases: where are we now?
por: Loh, Marie, et al.
Publicado: (2023)

From Polygenic Scores to Precision Medicine in Alzheimer’s Disease: A Systematic Review
por: Harrison, Judith R., et al.
Publicado: (2020)

Tread Lightly Interpreting Polygenic Tests of Selection
por: Novembre, John, et al.
Publicado: (2018)

Advances in Risk Prediction of Type 2 Diabetes: Integrating Genetic Scores With Framingham Risk Models
por: Keating, Brendan J.
Publicado: (2015)

Polygenic risk scores for melanoma: a stepwise process towards clinical implementation
por: Wakkee, Marlies
Publicado: (2022)

The limits of personalization in precision medicine: Polygenic risk scores and racial categorization in a precision breast cancer screening trial
por: James, Jennifer Elyse, et al.
Publicado: (2021)

The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for gXe research
por: Kirkbride, James B.
Publicado: (2014)

Getting the Most Out of Your Genome-Wide Association Study Using Polygenic Risk Scores
por: Maggioncalda, Emily, et al.
Publicado: (2023)

Precision Medicine: The new era in medicine
por: Twilt, Marinka
Publicado: (2016)

Role of Polygenic Risk Score in Cancer Precision Medicine of Non-European Populations: A Systematic Review
por: Junior, Howard Lopes Ribeiro, et al.
Publicado: (2022)

Prospects for using risk scores in polygenic medicine
por: Lewis, Cathryn M., et al.
Publicado: (2017)

Biomarkers for Alzheimer’s Disease (AD) and the Application of Precision Medicine
por: Lukiw, Walter J., et al.
Publicado: (2020)

Why rare disease needs precision medicine—and precision medicine needs rare disease
por: Might, Matthew, et al.
Publicado: (2022)

Pharmacological enrichment of polygenic risk for precision medicine in complex disorders
por: Reay, William R., et al.
Publicado: (2020)

Dissecting Polygenic Etiology of Ischemic Stroke in the Era of Precision Medicine
por: Li, Jiang, et al.
Publicado: (2022)

Capturing phenotypes for precision medicine
por: Robinson, Peter N., et al.
Publicado: (2015)

‘En route’ to precision medicine
por: Hijnen, D.J.
Publicado: (2019)

Experimental pharmacology in precision medicine
por: Urbaniak, Alicja, et al.
Publicado: (2023)

Testing for differences in polygenic scores in the presence of confounding
por: Blanc, Jennifer, et al.
Publicado: (2023)

Polygenic transcriptome risk scores (PTRS) can improve portability of polygenic risk scores across ancestries
por: Liang, Yanyu, et al.
Publicado: (2022)

Precision Medicine in Non-Communicable Diseases
por: Novelli, Giuseppe, et al.
Publicado: (2020)

Putting data to work for precision medicine
por: Bjerrum, Andreas, et al.
Publicado: (2023)

Polygenic risk scores: the future of cancer risk prediction, screening, and precision prevention
por: Wang, Yuzhuo, et al.
Publicado: (2022)

Understanding polygenic models, their development and the potential application of polygenic scores in healthcare
por: Babb de Villiers, Chantal, et al.
Publicado: (2020)

3421 Evaluation of novel biomarkers of hepatocellular carcinoma development and recurrence in liver transplant patients
por: Mancinelli, Jenna, et al.
Publicado: (2019)

Metabolomics: an emerging but powerful tool for precision medicine
por: Clish, Clary B.
Publicado: (2015)

The opportunity in African genome resource for precision medicine
por: Fatumo, Segun
Publicado: (2020)

Personalized Nursing Care in Precision-Medicine Era
por: Lopes-Júnior, Luís Carlos
Publicado: (2021)

Toward a precision medicine approach for autoimmunity
por: Kissler, Stephan
Publicado: (2022)

Personomics: The Missing Link in the Evolution from Precision Medicine to Personalized Medicine
por: Ziegelstein, Roy C.
Publicado: (2017)

Polygenic Risk Scores Contribute to Personalized Medicine of Parkinson’s Disease
por: Dehestani, Mohammad, et al.
Publicado: (2021)

Headaches and polygenic scores
por: Vilhjálmsson, Bjarni J., et al.
Publicado: (2019)

Polygenic Scores in the Direct-to-Consumer Setting: Challenges and Opportunities for a New Era in Consumer Genetic Testing
por: Park, Jin K., et al.
Publicado: (2023)

Precision medicine is here, break out your wallet
por: Hafez, Nabil
Publicado: (2014)

AIT (allergen immunotherapy): a model for the “precision medicine”
por: Passalacqua, Giovanni, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_3ht5mer2jpol858qtuspakusqc